Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel <i>R-Spondin2</i> RNA Fusion and <i>NTRK3</i> Mutation

Ampullary adenocarcinoma is a rare malignancy that lacks standard systemic treatment. We describe a case of recurrent metastatic ampullary adenocarcinoma of the pancreaticobiliary subtype treated with nanoparticle albumin-bound (nab)-paclitaxel and gemcitabine as first-line treatment. This report al...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maryknoll P. Linscott, Havell Markus, Mackenzie Sennett, Catherine Abendroth, Nelson S. Yee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-08-01
coleção:	Biomedicines
Assuntos:	ampullary adenocarcinoma pancreaticobiliary nab-paclitaxel gemcitabine molecular profiling circulating tumor DNA
Acesso em linha:	https://www.mdpi.com/2227-9059/11/8/2326
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!